CardioInsight Technologies Inc., a company headquartered at University Hospitals of Cleveland, has recently closed a $6 million Series B round of funding for further development of its cardiac Electrocardiographic Mapping (ECM) technology. Designed to improve the detection and 3D visualization of ectopic foci in arrhythmia patients, the company’s technology “combines body surface electrical data with heart-torso anatomical data to provide 3-D images of electrical activity for the entire heart, non-invasively and simultaneously.” The firm believes its patented technology, that combines body surface electrical data from a chest sensor array with detailed anatomical data from CT scans, can offer beat by beat EP mapping of the heart:
CardioInsight’s electrocardiographic mapping technology gathers electrical information about the heart from an electrode ‘vest’ placed on a patient’s body and combines it with images from a CT scan to provide 3D maps of the electrical activity of the heart. Unlike conventional methods, CardioInsight’s technology is non-invasive and provides beat-by-beat whole heart mapping. The technology’s strengths in guiding the treatment of arrhythmias and heart failure have been demonstrated in more than 125 pre-procedural and intra-procedural patient studies at clinical centers including University Hospitals of Cleveland, Loyola Chicago, and Hôpital Cardiologique du Haut–Lévèque in Bordeaux, France.
CardioInsight technology and product…
Press release: CardioInsight Technologies Closes $6 Million Funding Round…